Latest Reports

The “2021 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success. 

This report describes and forecasts performance by region for 11 categories of IOLs: commodity monofocal, enhanced monofocal/intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, postoperatively adjustable, and phakic IOLs.

The “2020 Refractive Surgery Market Report” analyzes the global refractive and presbyopia-correcting market, identifying important trends and key factors for future success. It focuses on the 2020 refractive and presbyopia-correcting surgical market and forecasts market growth and evolution over the next five years. Included are discussions and market estimates for LASIK, lenticular extraction, phakic IOLs, corneal inlays, refractive lens exchange (RLE), and other technologies that may disrupt the market.

On October 30, 2020, Market Scope invited 891 US ophthalmologists via our online survey portal to participate in part seven of a nine-part series of surveys to capture the impact of COVID-19 on ophthalmic practices. There were 117 participants, representing 33 states. This survey attracted a diverse group of doctors; 85 percent of respondents provide cataract surgery, 63 percent perform glaucoma surgery, 29 percent treat retina patients, and 31 percent provide cornea treatment. Most of these doctors offer multiple areas of treatment. All individual responses are kept strictly confidential, and we report only aggregate data.

The report offers a comprehensive analysis of the 2021 global market in cataract surgical equipment, as well as a discussion of important trends and key factors for future success. The report looks at the market’s evolution and forecasts growth over the next five years.

Market Scope has published the Ophthalmic Market Perspectives (OMP) newsletter for more than 20 years. The newsletter provides the latest business information that is shaping ophthalmic markets and professions. Our articles explore new technologies and company developments. We offer opinions on issues facing the industry. We also analyze and chart quarterly industry data, and we forecast market performance over time.

The “2021 Glaucoma Surgical Device Market Report” offers a comprehensive analysis of the current global market for glaucoma devices, as well as a discussion of important trends and key factors shaping future success. The report covers prevalence for glaucoma worldwide and discusses the ophthalmologists who treat glaucoma. It also examines the role of surgical intervention, the market dynamics for currently commercialized products, and the pipeline of investigational devices that may offer improved outcomes. Product demand is forecast in units and dollars, and market shares are analyzed by product category.

Market Scope’s 2021 Glaucoma Disease Model offers extensive country-level prevalence data and five-year forecasts for glaucoma by type and by age group for all countries with a population over a million.

This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients’ diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.

Our coverage of the US glaucoma surgery market includes a quarterly surveying process that targets and collects data from glaucoma surgeons. The resulting data are analyzed and presented in our US Glaucoma Surgery Quarterly Updates. These updates are designed to improve your decision-making process with an assessment of current market conditions and the identification of significant market trends -- including a variety of vital practice of medicine issues, doctors’ evaluations of pharmaceuticals and surgical equipment, product use and market share, product adoption plans, and the identification of significant trends in the marketplace for the treatment of glaucoma. 

Each update includes full-year forecasts, comparisons with prior years, and trend analysis.

The “2021 United States Retina Atlas” provides a geographic analysis of retinal treatment opportunity and key demographic metrics in 85 US metropolitan areas. Market Scope’s proprietary MedOp Index™ Analysis examines market potential and provides a benchmark against other metros. The Retina Atlas offers strategic insights into the top potential markets in the US by providing demographic information of selected metropolitan populations, and profiles of selected metropolitan areas and applicable retinal treatment opportunity, current estimates for retina surgery volume by metropolitan area, current estimates for retina surgeons by metropolitan area, and comprehensive directory of US ophthalmic practices performing retinal IVTs and vitrectomies.

The “2021 China Ophthalmic Market Report” is the leading industry source for accurate and relevant information on all aspects of China’s ophthalmic market. This report provides a comprehensive overview of the Chinese population and economic conditions. It also covers disease prevalence and therapeutic approaches, including commercialized and pipeline products. The report analyzes unit demand and revenue and forecasts future performance over the next five years. It also includes market share data and discusses key strategic issues.